Skip to content
GradedGrading live · 2026
LongevityGraded
Menu

Graded review

How Much Does a Longevity Clinic Cost?

Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.

Researched & graded by Tom Vance · Lead Reviews Analyst
Last graded
Evidence scorecard

Ask "how much does a longevity clinic cost?" and the honest answer is anywhere from about $200 a year to well over $100,000 — because "longevity clinic" describes at least four completely different products. A direct-to-consumer lab membership that mails you a test kit and a $20,000-a-year concierge program with its own MRI scanner both market themselves as "longevity," but you are buying very different things. This guide gives you real 2026 price bands, what each tier actually delivers, and — the part most clinics won't tell you — where the spending is and isn't supported by evidence.

The single most useful frame before any number: almost everything sold as "longevity" is priced on a promise the field hasn't yet proven. No intervention offered by any of these clinics has been shown in a completed randomized trial to extend human lifespan. The validated biomarkers and outcome endpoints that would let you measure "did this slow my aging?" are still being selected for trials1. So as you read the prices, keep asking the question that reorganizes the whole market — am I paying for a diagnostic picture, an ongoing treatment plan, or just a rising lab value? We map the full market in longevity clinics vs lab memberships vs Rx telehealth, and the evidence behind the claims in longevity medicine: what's proven vs hyped.

The price bands at a glance (as of June 2026)

| Band | Typical price (2026) | What you get | Honest catch | |---|---|---|---| | DTC lab membership | ~$199–$365/yr | 100–160+ biomarkers, biological-age estimate, MD review of abnormals | Tests but largely doesn't treat | | Single-product Rx telehealth | ~$99–$235/mo (often pay-per-use) | One therapy line — TRT, peptides, rapamycin, NAD+, GLP-1 | Narrow; vertical-pharmacy conflict common | | Membership longevity program | ~$99–$300/mo (~$1,200–$3,600/yr) | Recurring labs + prescribing clinician + retesting + therapies | "Healthspan" claims; supplement/Rx upsells | | Concierge diagnostic clinic | ~$3,000–$25,000/yr (some packages higher) | Whole-body/brain MRI, coronary CT, genomics, in-person MD | Over-screening risk; unproven "reverse-aging" bolt-ons |

Prices are 2026 figures published by the providers themselves and may vary by state and package; verify current pricing before you buy. The rest of this guide walks each band, then asks the only question that matters — is any of it worth it over a good primary-care doctor and a few DIY labs?

2026 Price Bands at a Glance

BandPrice (2026)What you actually getHonest catch
DTC lab membership~$199–$365/yr100–160+ biomarkers, biological-age estimate, MD review of abnormalsTests but does not treat — hands you off
Single-product Rx telehealth~$99–$235/moOne therapy (TRT, peptides, rapamycin, NAD+, GLP-1) with light clinical oversightVertical-pharmacy conflict common; longevity framing often ahead of the evidence
Membership longevity program~$99–$300/moRecurring labs, prescribing clinician, retesting, and therapy menu"Healthspan" claims; GH red flag; supplement and Rx upsells
Concierge diagnostic clinic~$3,000–$25,000+/yrWhole-body/brain MRI, coronary CT, genomics, 100+ biomarkers, in-person MDOver-screening risk; bolt-on unproven "reverse aging" therapies
None of these bands has been shown to extend human lifespan. The honest question for each tier: am I paying for a diagnostic picture, an ongoing treatment plan, or just a rising lab value?

Band 1: DTC lab memberships — ~$199–$365/year

This is the cheapest on-ramp, and for many people the most rational one. Function Health charges about $365/yr for 160+ biomarkers across two annual draws plus physician review of anything abnormal; Superpower runs about $199/yr (higher in some states) for 100+ markers, a biological-age readout, and text access to a clinician. You mail in or visit a lab, get a large panel back, and receive an interpretation.

What you're really paying for: breadth of testing at a low price — a once- or twice-a-year snapshot of cardiometabolic, hormonal, and inflammatory markers most annual physicals don't cover.

The honest catch: this band tests but largely doesn't treat. It hands you results and, for most findings, hands you off. The "biological age" number these services feature is also softer than it looks — different methods produce different ages from the same blood, and the field still lacks an agreed, validated clinical aging biomarker1. Treat the panel as useful raw data and the biological-age figure as a motivational estimate, not a verdict. We dig into that in biological age tests: do epigenetic clocks work? and what the panels actually measure in what do longevity biomarker panels actually test?.

Band 2: Single-product Rx telehealth — ~$99–$235/month

Here you're buying one therapy line, not a program. Examples in 2026: sermorelin around $99/mo, NAD+ injections around $235/mo, compounded GLP-1s around $139/mo, or TRT around $225/mo through hormone-optimization brands. Many run pay-per-use rather than a flat membership.

What you're really paying for: convenient prescription access to a specific intervention — a peptide, a hormone, rapamycin, or a GLP-1 — with light clinical oversight.

The honest catch: the evidence under each product varies enormously, and so does the conflict of interest. Several of these brands dispense through their own pharmacy, so the company recommending the therapy also profits from selling it. And the longevity framing is often ahead of the data: a landmark systematic review of growth hormone in healthy older adults found small body-composition changes but no proven functional benefit and significantly more adverse events2 — a cautionary template for how a plausible-sounding hormone or peptide can be marketed as "anti-aging" without outcome data behind it. Rapamycin and NAD+ sit in the same place: real mechanisms, no completed human longevity trial. See rapamycin & metformin: what the evidence shows and do NAD+ and longevity peptides work?.

Band 3: Membership longevity programs — ~$99–$300/month

This is the band most people mean by "longevity clinic" once they want ongoing care rather than a one-time test. Lifeforce runs about $149/mo after a roughly $549 diagnostic; multi-service clinics tier from about $99 to $399/mo. The model is recurring: a 40–100-marker panel, retesting every few months, a clinician who reviews results and prescribes, and a menu of therapies — hormones, peptides, GLP-1s, NAD+ — usually over telehealth with mailed lab kits, which is why it costs a fraction of concierge pricing.

What you're really paying for: the thing a DTC lab won't give you and a single Rx product can't — a prescribing clinician plus a retesting cadence, so you can actually see whether an intervention moved your numbers over time. This is the only accessible-price band built for longitudinal treatment.

The honest catch: this band leans hardest on the word "healthspan," and much of what it prescribes has mechanistic plausibility but no completed human longevity RCT. Two things to vet specifically: vertical-pharmacy conflict (does the program profit from the drugs it recommends?) and the growth-hormone red flag above. A physician-overseen peptide/NAD+/GLP-1 membership that distinguishes proven from plausible and discloses its conflicts is the credible version of this band; one that pitches everything as equally "proven" is not. We weigh the two hands-on models head-to-head in concierge vs membership longevity: what you actually get, and grade providers on exactly these axes in how we grade longevity providers.

Band 4: Concierge diagnostic clinics — ~$3,000–$25,000+/year

The premium ceiling. Fountain Life lists a ~$2,995/yr core tier and a flagship around $19,500/yr; Human Longevity's concierge tiers reach roughly $19,000/yr; Cenegenics programs land around $14,000–$21,000/yr once you add the assessment and monthly fees. Some bespoke packages run higher still. The product is diagnostics you genuinely cannot get elsewhere as a consumer: whole-body and brain MRI, coronary CT angiography with AI plaque analysis, whole-genome sequencing, 100+ biomarkers, and a physician quarterbacking all of it in person.

What you're really paying for: depth and imaging. For some people, a scan catches something important early — the legitimate case for the model.

The honest catch — over-screening: intensive scanning of asymptomatic people is genuinely double-edged, and the data are now specific. A 2026 systematic review and meta-analysis of whole-body MRI across more than 9,000 asymptomatic individuals found a confirmed-cancer detection rate of just 1.57%, alongside frequent incidental findings, unstandardized protocols, and no long-term outcome or cost-effectiveness data — concluding the scans "may lead to unnecessary investigations"3. In plain terms: the imaging that anchors the concierge pitch finds real cancer in about 1 in 64 healthy people while flagging far more ambiguous spots that drive anxiety, follow-up procedures, and cost. The second concierge catch is the bolt-on — plasma exchange, EBOO, NAD+, growth-hormone secretagogues attached to the diagnostic core. Treat the imaging and genomics as the real product and the "reverse aging" add-ons as unproven. The full case is in are longevity clinics worth it?.

Is any of it worth it vs a good PCP and DIY labs?

Here's the comparison clinics rarely volunteer. A competent primary-care physician will already order the basics that drive most of the value — lipids, A1c, blood pressure, a metabolic panel, thyroid — typically covered by insurance. You can add the markers most physicals skip (ApoB, hs-CRP, fasting insulin, a fuller lipid and hormone panel) through a DTC lab for one to a few hundred dollars a year. That combination captures the large majority of actionable information a longevity clinic surfaces, at a fraction of the price.

What the paid bands add over PCP-plus-DIY-labs:

  • DTC memberships add breadth and packaging — convenient, but you're paying mostly for a tidier dashboard and a biological-age number that isn't a validated clinical endpoint1.
  • Membership programs add the genuinely useful piece a PCP often won't do: prescribe and monitor optimization therapies (peptides, hormones, GLP-1s) with structured retesting. If you specifically want those therapies and want them overseen, this is the rational paid tier.
  • Concierge clinics add advanced imaging and genomics — real capability, but aimed at asymptomatic screening, where the evidence shows modest cancer yield and meaningful over-diagnosis risk3.

The strongest human-outcome evidence in the entire field belongs to GLP-1 receptor agonists — the SELECT trial showed semaglutide cut major cardiovascular events by about 20% in overweight and obese adults without diabetes4 — and even that proves cardiovascular risk reduction, not slowed aging. Most other longevity interventions, including the ones priced highest, target mechanisms and biomarkers rather than proven outcomes; metformin, for instance, plausibly attenuates several hallmarks of aging in mechanistic work, but the trial designed to test whether it actually extends healthy years (TAME) hasn't read out5. That's the core honesty of this whole price question: in most cases you are paying to move a lab value, not a proven outcome.

A reasonable spending ladder for most people: start with a good PCP and one DTC lab panel a year (lowest cost, most of the actionable signal); step up to a membership program only if you specifically want prescribed, monitored optimization therapies; and treat concierge imaging as an optional, eyes-open luxury you buy for the diagnostic picture, not as proven life extension. What you should never do is pay concierge prices expecting a treatment plan, or membership prices expecting concierge-grade imaging.

For our independently graded shortlist across every band — with prices, oversight, and unproven claims flagged honestly — see our longevity clinic rankings. And if you're not sure you need a clinic at all, start with what a longevity doctor actually does (and who needs one).

This article is general health and consumer-finance information, not medical or financial advice. Prices are 2026 figures and change frequently; verify current pricing and discuss any therapy with a licensed clinician before starting.

Frequently asked questions

How much does a longevity clinic cost in 2026?

It spans a huge range because 'longevity clinic' covers four different products. DTC lab memberships run about $199–$365/yr; single-product Rx telehealth (peptides, TRT, NAD+, GLP-1) about $99–$235/mo; membership longevity programs about $99–$300/mo (roughly $1,200–$3,600/yr); and concierge diagnostic clinics with imaging and genomics about $3,000–$25,000+/yr. Prices are 2026 figures and vary by state and package.

Why are concierge longevity clinics so expensive?

You're paying for diagnostics you can't get elsewhere as a consumer — whole-body and brain MRI, coronary CT angiography, whole-genome sequencing, 100+ biomarkers, and an in-person physician. The catch is that intensive screening of healthy people has real over-diagnosis risk: a 2026 meta-analysis of whole-body MRI in over 9,000 asymptomatic adults found just a 1.57% cancer-detection rate alongside frequent incidental findings that may trigger unnecessary investigations.

Is a longevity clinic worth it over a regular doctor and DIY labs?

For most people, a good primary-care physician plus one direct-to-consumer lab panel a year (adding ApoB, hs-CRP, fasting insulin and a fuller hormone panel) captures the majority of actionable information at a fraction of the cost. Pay for a membership program only if you specifically want prescribed, monitored optimization therapies; treat concierge imaging as an optional luxury for the diagnostic picture, not as proven life extension.

Do longevity clinics actually extend your lifespan?

No intervention sold by any of these clinics has been shown in a completed randomized trial to extend human lifespan. The strongest human-outcome data belongs to GLP-1 drugs (the SELECT trial showed semaglutide cut cardiovascular events about 20%), and even that proves cardiovascular risk reduction, not slowed aging. Most longevity interventions move biomarkers and mechanisms, not proven outcomes — so you're often paying to change a lab value, not to add years.

What's the cheapest way to start with longevity testing?

A DTC lab membership at roughly $199–$365/yr is the lowest-cost on-ramp, giving you 100–160+ biomarkers and a biological-age estimate. Just treat the panel as useful raw data and the biological-age number as a motivational estimate rather than a validated clinical verdict — the field still lacks an agreed, validated aging biomarker.

References

  1. Justice JN, Ferrucci L, Newman AB, et al. (2018). A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. GeroScience. https://pubmed.ncbi.nlm.nih.gov/30151729/
  2. Liu H, Bravata DM, Olkin I, et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine. https://pubmed.ncbi.nlm.nih.gov/17227934/
  3. Martins da Fonseca J, Trennepohl T, Pinheiro LG, et al. (2026). Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis. European Radiology. https://pubmed.ncbi.nlm.nih.gov/40884613/
  4. Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/37952131/
  5. Kulkarni AS, Gubbi S, Barzilai N (2020). Benefits of Metformin in Attenuating the Hallmarks of Aging. Cell Metabolism. https://pubmed.ncbi.nlm.nih.gov/32333835/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

More graded reviews